Bcr-Abl Exerts Its Antiapoptotic Effect Against Diverse Apoptotic Stimuli Through Blockage of Mitochondrial Release of Cytochrome C and Activation of Caspase-3 [PDF]
, 1998 Gustavo P. Amarante‐Mendes +6 more
openalex +1 more source
INVESTIGATING ALLOSTERIC REGULATION OF ABL AND BCR-ABL KINASES: IMPLICATIONS FOR SMALL MOLECULE INHIBITORS [PDF]
, 2012 BCR-ABL is the oncogenic protein-tyrosine kinase responsible for the pathogenesis of chronic myelogenous leukemia (CML). Clinical management of CML has been revolutionized by imatinib, a selective ATP-competitive inhibitor of BCR-ABL kinase activity ...
PANJARIAN, SHOGHAG
core +1 more source
Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia. [PDF]
Pathol Oncol Res, 2023 Hasanova A +5 more
europepmc +1 more source
Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation [PDF]
, 1996 Feng Lin +3 more
openalex +1 more source
BCR/ABL rearrangement and leukemia phenotype [PDF]
Leukemia, 1999 SAGLIO, Giuseppe +3 more
openaire +4 more sources
Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors. [PDF]
PLoS One, 2023 Wang Y +7 more
europepmc +1 more source
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis [PDF]
, 1998 Danilo Perrotti
openalex +1 more source
Inhibition of BCR-ABL Expression With Antisense Oligodeoxynucleotides Restores β1 Integrin-Mediated Adhesion and Proliferation Inhibition in Chronic Myelogenous Leukemia Hematopoietic Progenitors [PDF]
, 1998 Ravi Bhatia, Catherine M. Verfaillie
openalex +1 more source
The BCR-ABL oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion [PDF]
, 1996 Anderson Sm, J Mladenovic
openalex +1 more source